Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Curr Bioact Compd. 2010 Mar 1;6(1):60–75. doi: 10.2174/157340710790711737

Table 2.

Plasma and Vascular Levels of Bioactive Factors and Vascular Mediators during Norm-Preg and HTN-Preg in rats.

Site of Action Effect Norm-Preg HTN-Preg Reference
Bioactive Factor
VEGF Endothelium Vasorelaxation 830±33 pg/mL 594±34 pg/mL [42]
sFlt-1 Endothelium Anti VEGF 82±26 pg/mL 660±270 pg/mL [43]
Endoglin Endothelium Anti TGF-β 8 ng/mL 17 ng/mL [44]
Cytokines
TNF-α
IL-6

Endothelium
Endothelium

EC Dysfunction
EC Dysfunction

8±1 pg/mL
36.6±7 pg/mL

48±13 pg/mL
104.5±28.6 pg/mL

[45]
[46]
HIF DNA Gene Transcription ↑↑ [27]
ROS Endothelium EC Dysfunction -- [27]
Vascular Mediator
NO (Urinary Nitrite/Nitrate) VSM Vasorelaxation 46.4±5.3 μmol/24 hr 49.8±6.4 μmol/24 hr [47]
PGI2 VSM Vasorelaxation [48]
ET-1 VSM, Endothelium Vasoconstriction, Vasorelaxation 1.7 pmol/L 2.2 pmol/L [49]
AngII VSM Vasoconstriction [50]
VSM [Ca2+]i
- Basal
- PHE (10−5M)
- AngII (10−7M)

Myofilaments
Myofilaments
Myofilaments

Basal Tone
Contraction
Contraction

63 ± 5 nM
149 ±8 nM
149 ±8 nM

109 ± 8 nM
234 ±1 nM
225 +/− 9 nM

[51]
[51]
[52]

↑↑, Greatly increased;

↑, Increased;

↓, Decreased;

--, No change, relative to nonpregnant.